LUZZI, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 1.452
EU - Europa 1.149
AS - Asia 608
OC - Oceania 9
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 3.230
Nazione #
US - Stati Uniti d'America 1.445
IE - Irlanda 266
CN - Cina 215
SG - Singapore 194
IT - Italia 187
UA - Ucraina 186
SE - Svezia 152
TR - Turchia 142
DE - Germania 84
GB - Regno Unito 56
FR - Francia 43
RU - Federazione Russa 41
ES - Italia 40
FI - Finlandia 35
IN - India 30
PL - Polonia 17
AU - Australia 9
CZ - Repubblica Ceca 9
BE - Belgio 7
PT - Portogallo 7
BR - Brasile 5
JP - Giappone 5
AT - Austria 4
CA - Canada 4
IR - Iran 4
KR - Corea 4
NL - Olanda 4
ID - Indonesia 3
TH - Thailandia 3
TW - Taiwan 3
VN - Vietnam 3
AR - Argentina 2
CH - Svizzera 2
EU - Europa 2
HR - Croazia 2
NI - Nicaragua 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 3.230
Città #
Jacksonville 280
Chandler 258
Dublin 255
Singapore 167
Princeton 110
Nanjing 82
Izmir 72
Altamura 53
Wilmington 51
Santa Clara 50
Cambridge 42
Nanchang 38
Ann Arbor 37
Southend 36
Ashburn 34
Dearborn 27
Menlo Park 26
New York 18
Santa Pola 18
Beijing 17
Boardman 16
Calpe 12
Hebei 12
Shenyang 12
Jiaxing 11
Kunming 11
Chieti 10
Brussels 7
Istanbul 7
Los Angeles 7
San Mateo 6
Shanghai 6
Tianjin 6
Washington 6
Brno 5
Falls Church 5
Kraków 5
Lanzhou 5
Leawood 5
Milan 5
Norwalk 5
Offenbach 5
Rome 5
San Michele al Tagliamento 5
Warsaw 5
Woodbridge 5
Darmstadt 4
Hanover 4
Helsinki 4
Houston 4
Madrid 4
Munich 4
Mérignac 4
Bergamo 3
Bologna 3
Catania 3
Changsha 3
Forlì 3
Jakarta 3
Mountain View 3
Pamplona 3
Redwood City 3
Reston 3
Rimini 3
San Jose 3
Sydney 3
Toronto 3
Abbiategrasso 2
Amsterdam 2
Atlanta 2
Augusta 2
Bangkok 2
Bari 2
Bath 2
Changchun 2
Charleston 2
Dallas 2
Delhi 2
Denver 2
Dong Ket 2
Ferrara 2
Guardiagrele 2
Hangzhou 2
Jinan 2
Lexington 2
Lodz 2
Long Beach 2
Managua 2
Maple Valley 2
Mersin 2
Moscow 2
New Taipei City 2
Ningbo 2
Palermo 2
Pescara 2
Pistoia 2
Post Falls 2
Pyeongtaek-si 2
San Diego 2
San Giuliano Milanese 2
Totale 1.996
Nome #
Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections 153
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 124
Effects of collagen remodulation with Centella asiatica (Centellicum®) in Dupuytren palmar fibromatosis: a pilot supplement study 106
Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events 104
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 99
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 92
Moderate, diffuse, somatic muscular pain: Effects of supplementation with a Pycnogenol patch 91
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 89
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 85
Phytochemical investigation on Gentian roots from populations of Gran Sasso and Monti della Laga National Park 82
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 80
Supplementation with Robuvit® in subjects with burnout associated to high oxidative stress 79
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 78
Robuvit®: improvement of fatigue in medical convalescence. 76
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 73
Ethnomedicine and phytochemistry of the genus Potentilla 70
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 70
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 70
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 66
Pycnogenol® supplementation in minimal cognitive dysfunction 66
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 65
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 65
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 63
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 61
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 60
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol (R) 60
Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum® 60
Improvement of common cold with Pycnogenol®: a Winter registry study. 59
Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. 58
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome 58
Lady Prelox® improves sexual function in generally healthy women of reproductive age. 56
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®. 55
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study. 54
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol® 54
Pycnogenol® supplementation improves cognitive function, attention and mental performance in students. 52
Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. 50
Pycnogenol® in postpartum symptomatic hemorrhoids. 50
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 49
Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy. 49
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 48
Pycnogenol and Centella Asiatica for preventing asymptomatic atherosclerosis progression into clinical events. 47
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. 46
Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome. 45
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome. 45
Improvements of venous tone with pycnogenol in chronic venous insufficiency: an ex vivo study on venous segments. 43
Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. 40
Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression. 40
Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. 39
Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. 36
Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study. 36
Pycnogenol® improvements in asthma management. 36
Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55. 34
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. 32
Primary benign back pain: supplementation with Pycnogenol® 23
Totale 3.421
Categoria #
all - tutte 12.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 0 12 9 65 22 60 48 22 31 109 16
2020/2021268 49 2 64 7 16 65 5 9 10 9 21 11
2021/2022235 9 7 0 43 23 8 13 15 11 7 33 66
2022/2023769 68 111 34 78 68 154 46 67 95 13 26 9
2023/2024404 21 17 30 13 24 85 148 19 9 11 3 24
2024/2025375 66 182 127 0 0 0 0 0 0 0 0 0
Totale 3.421